Some candidate tumor antigens have been assessed as the best immunogenic antigens in anticancer phage-based vaccines, such as Epidermal Growth Factor Receptor (EGFR) [72], Fms-like tyrosine kinase 4 (Flt4), and Melanoma Antigen Gene (MAGE) [77]. The gene discussed is EGFR; the disease is neoplasm.